Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion

This publication has 27 references indexed in Scilit:

• ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma
  The Lancet, 1998
• Effectiveness of bronchodilators in cystic fibrosis
  The American Journal of Medicine, 1996
• Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis
  Nature Medicine, 1995
• Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations
  Molecular and Cellular Probes, 1992
• Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease.
  BMJ, 1991
• Chronic obstructive lung disease in Copenhagen: cross‐sectional epidemiological aspects
  Journal of Internal Medicine, 1989
• Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis.
  Thorax, 1987
• CYSTIC FIBROSIS HETEROZYGOSITY IN THE PATHOGENESIS OF ALLERGY
  The Lancet, 1976
• Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis.
  Archives of Disease in Childhood, 1975
• Anamnesis, Sweat Electrolyte and Pulmonary Function Studies in Parents of Patients with Cystic Fibrosis of the Pancreas1
  Acta Paediatrica, 1963